SUMMARY OF RECENT ACTIVITY

​

The RMTAG is currently developing a labeling standard for tissue-engineered products to support uniform electronic encoding of key product information, help minimize manual transcription errors, use internationally standardized terminology, and enable global traceability and trade. Therefore, the committee members were invited to participate in the survey “Development of a global standard for the labeling of tissue-engineered products.” The survey was circulated in October 2022 and intended to gather input from key stakeholders on the label design to ensure users benefit fully from the resulting standard.

 

Proposal 19-002 v2—New data structure for constituent MPHO elements of a product—was approved by the RMTAG, the Cellular Therapy Coding and Labeling Advisory Group (CTCLAG), and the Standards Committee. ICCBBA is working on the implementation of this new data structure.

 

Since June 2022, the RMTAG Discussion Forum has been active in Loomio. The purpose of this forum is to provide an all-in-one platform where members can carry out discussions on proposed additions or changes to the ISBT 128 Standard and collaborate to reach a consensus.